Raymond James Financial Services Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,118
Closed -$77.9K 3473
2024
Q1
$77.9K Sell
10,118
-275
-3% -$2.21K ﹤0.01% 3254
2023
Q4
$91.1K Sell
10,393
-3,392
-25% -$24.8K ﹤0.01% 3139
2023
Q3
$100K Hold
13,785
﹤0.01% 3063
2023
Q2
$91.1K Sell
13,785
-30
-0.2% -$153 ﹤0.01% 3075
2023
Q1
$47.1K Sell
13,815
-2,163
-14% -$8.38K ﹤0.01% 3130
2022
Q4
$44.4K Buy
15,978
+1,795
+13% +$5.37K ﹤0.01% 3095
2022
Q3
$41K Hold
14,183
﹤0.01% 3105
2022
Q2
$49K Hold
14,183
﹤0.01% 3092
2022
Q1
$67K Sell
14,183
-6,750
-32% -$33K ﹤0.01% 3161
2021
Q4
$126K Sell
20,933
-3,900
-16% -$27.1K ﹤0.01% 3084
2021
Q3
$150K Sell
24,833
-1,193
-5% -$13.4K ﹤0.01% 3052
2021
Q2
$326K Buy
26,026
+2,778
+12% +$30.1K ﹤0.01% 2662
2021
Q1
$239K Buy
23,248
+1,618
+7% +$15.6K ﹤0.01% 2793
2020
Q4
$196K Buy
+21,630
New +$156K ﹤0.01% 2724
2018
Q4
Sell
-64,828
Closed -$401K 2716
2018
Q3
$401K Buy
64,828
+3,371
+5% +$15.2K ﹤0.01% 2088
2018
Q2
$393K Buy
+61,457
New +$437K ﹤0.01% 2048
2018
Q1
Sell
-57,037
Closed -$719K 2663
2017
Q4
$719K Buy
57,037
+3,294
+6% +$40.2K ﹤0.01% 1494
2017
Q3
$638K Sell
53,743
-1,357
-2% -$20.1K ﹤0.01% 1578
2017
Q2
$825K Buy
55,100
+1,882
+4% +$25.1K 0.01% 1384
2017
Q1
$507K Sell
53,218
-1,500
-3% -$12.7K ﹤0.01% 1565
2016
Q4
$485K Sell
54,718
-2,731
-5% -$24.5K ﹤0.01% 1534
2016
Q3
$493K Sell
57,449
-5,828
-9% -$46.2K ﹤0.01% 1505
2016
Q2
$505K Buy
63,277
+6,754
+12% +$52.6K ﹤0.01% 1417
2016
Q1
$494K Buy
56,523
+6,862
+14% +$57K 0.01% 1259
2015
Q4
$465K Buy
49,661
+13,478
+37% +$117K 0.01% 1234
2015
Q3
$349K Buy
+36,183
New +$382K 0.01% 1191

Other funds holding MDXG

Raymond James Financial Services Advisors's MDXG Position: Q2 2024 in Review

Raymond James Financial Services Advisors sold out of MiMedx Group (MDXG) in Q2 2024, closing a stake of 10,118 shares — an estimated $77.9K sold.

Raymond James Financial Services Advisors first reported a position in MDXG in Q3 2015 and held it in 26 quarters. The position peaked at $825K in Q2 2017. 202 funds tracked by Wall St. Rank hold MDXG as of Q2 2024.

  • Raymond James Financial Services Advisors reported no remaining MiMedx Group position as of Q2 2024 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 10,118 MiMedx Group shares in Q2 2024, an estimated $77.9K.
  • Raymond James Financial Services Advisors first reported a position in MiMedx Group in Q3 2015 and held it in 26 quarters.
  • Raymond James Financial Services Advisors's MiMedx Group position peaked at $825K in Q2 2017.
  • 202 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.